Condition: Pre-Eclampsia; Complicating Pregnancy · Antiphospholipid Syndrome in Pregnancy · Pulmonary Hypertension · Sponsor: Insel Gruppe AG, University Hospital Bern
The primary goal of this observational study is to learn about postpartum pulmonary artery pressure in women who suffered from Preeclampsia and Antiphospholipid Syndrome. The main question it aims to answer is whether the conjunction of preeclampsia with obstetric antiphospholipid syndrome significantly foster the development of long-lasting pulmonary hypertension. Only participants who suffered from preeclampsia during pregnancy will be followed for a period up to 3 years postpartum. Researchers will compare women with or without obstetric antiphospholipid syndrome.
This description comes directly from the study's public registry record.
Emrush Rexhaj, MD · +41 31 632 21 11 · emrush.rexhaj@insel.ch
Always discuss trial participation with your own doctor first.
| Inselspital | Bern, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05679206